Becoming (Commercial Products) Overview

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 8

Becoming (Commercial Products) General Information

Description

Developer of a developmental intelligence platform designed to predict how organisms change over time. The company offers robotic metabolic exchange systems, closed-loop hardware for real-time physiological regulation, dynamical AI models for virtual organisms, nutrient delivery systems, waste removal mechanisms, and gas exchange control systems, providing biotechnology companies with a system that sustains, perturbs, and predicts mammalian development externally to test interventions and understand disease failures.

Contact Information

Website
www.becoming.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Montevideo
  • Uruguay
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Enterprise Systems (Healthcare)
Medical Supplies
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences
Corporate Office
  • Montevideo
  • Uruguay

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Becoming (Commercial Products) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 09-May-2025 Completed Stealth
1. Early Stage VC 01-Dec-2024 Completed Stealth
To view Becoming (Commercial Products)’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Becoming (Commercial Products) Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
ACME Capital Venture Capital Minority
Long Journey Ventures Venture Capital Minority
Ritual Capital Venture Capital Minority
SNR Venture Capital Minority
Transpose Platform Management Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Becoming (Commercial Products) FAQs

  • Where is Becoming (Commercial Products) headquartered?

    Becoming (Commercial Products) is headquartered in Montevideo, Uruguay.

  • What industry is Becoming (Commercial Products) in?

    Becoming (Commercial Products)’s primary industry is Discovery Tools (Healthcare).

  • Is Becoming (Commercial Products) a private or public company?

    Becoming (Commercial Products) is a Private company.

  • What is Becoming (Commercial Products)’s current revenue?

    The current revenue for Becoming (Commercial Products) is .

  • Who are Becoming (Commercial Products)’s investors?

    ACME Capital, Long Journey Ventures, Ritual Capital, SNR, and Transpose Platform Management are 5 of 8 investors who have invested in Becoming (Commercial Products).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process